Johannes Nowatzky
Director, Behçet's Disease Program (BD-PRO), Stanford University · Stanford Health Care
Credentials: · · ·
History
- Present
- Present
- 2010–2012
New York University Division of Rheumatology (2012) NY
New England Eye Center
- 2003–2004
Research
Review · Annals of the Rheumatic Diseases · 2023 · 65 citations
Case report · Clinical and Experimental Rheumatology · 2012 · 37 citations
Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity
Annals of the Rheumatic Diseases · 2022 · Last of 9 authors · Corresponding · 34 citations
3 papers · 2 as a resident
- JM
2 papers · 1 as a fellow
2 papers
1 paper · 1 as a fellow
1 paper · 1 as a resident
1 paper
- JF
1 paper · 1 as a resident
- JG
1 paper
Grants
- 2022–2027
Modulation of Immunodominance in HLA Class I Associated Uveitides
National Eye Institute · R01
Contact PI · $1.8M · Stanford University
- 2021–2026
Unraveling the Role of HLA-B51/ERAP1 in Behcet's Eye Disease
National Eye Institute · R01
Contact PI · $2.1M · Stanford University
- 2015–2020
Harnessing Monoclonal Treg for the Treatment of Autoimmune Uveitis
National Eye Institute · K08
Contact PI · $906.8K · New York University School of Medicine